EXVIVO T-CELL DEPLETION WITH THE MONOCLONAL-ANTIBODY CAMPATH-1 PLUS HUMAN-COMPLEMENT EFFECTIVELY PREVENTS ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引:71
|
作者
HEIT, W [1 ]
BUNJES, D [1 ]
WIESNETH, M [1 ]
SCHMEISER, T [1 ]
ARNOLD, R [1 ]
HALE, G [1 ]
WALDMANN, H [1 ]
HEIMPEL, H [1 ]
机构
[1] UNIV CAMBRIDGE, DEPT PATHOL, CAMBRIDGE, ENGLAND
关键词
D O I
10.1111/j.1365-2141.1986.tb02203.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:479 / 486
页数:8
相关论文
共 50 条
  • [31] QUANTITATION OF HUMAN-BONE MARROW T-CELLS AFTER INVITRO DEPLETION BY THE MONOCLONAL-ANTIBODY CAMPATH-1
    IRLE, C
    KAESTLI, M
    CHAPUIS, B
    JEANNET, M
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 115 (43) : 1517 - 1518
  • [32] IMMUNOHISTOCHEMICAL ANALYSIS OF T-CELL PHENOTYPES IN PATIENTS WITH GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    DIAMOND, DJ
    CHANG, KL
    JENKINS, KA
    FORMAN, SJ
    TRANSPLANTATION, 1995, 59 (10) : 1436 - 1444
  • [33] ATTEMPTS AT T-CELL DEPLETION USING OKT3 AND RABBIT COMPLEMENT TO PREVENT ACUTE GRAFT VERSUS HOST-DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BLACKLOCK, HA
    PRENTICE, HG
    GILMORE, MJML
    PRICEJONES, E
    SCHEY, S
    TIDMAN, N
    MA, DDF
    GOLDSTEIN, G
    JANOSSY, G
    HOFFBRAND, AV
    EXPERIMENTAL HEMATOLOGY, 1983, 11 : 37 - 39
  • [34] GVHD PROPHYLAXIS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION USING T-CELL DEPLETION BY CAMPATH-I AND COMPLEMENT
    WIESNETH, M
    ARNOLD, R
    BUNJES, D
    HERTENSTEIN, B
    SCHMEISER, T
    HALE, G
    HEIMPEL, H
    HEIT, W
    LEUKEMIA RESEARCH, 1986, 10 (01) : 121 - 121
  • [35] PRETREATMENT OF DONOR BONE-MARROW WITH MONOCLONAL-ANTIBODY OKT3 FOR PREVENTION OF ACUTE GRAFT VERSUS HOST-DISEASE IN ALLOGENEIC HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATION
    FILIPOVICH, AH
    RAMSAY, NKC
    WARKENTIN, PI
    MCGLAVE, PB
    GOLDSTEIN, G
    KERSEY, JH
    LANCET, 1982, 1 (8284) : 1266 - 1269
  • [36] ELIMINATION OF T-CELLS FROM ALLOGENEIC BONE-MARROW GRAFTS BY INVITRO INCUBATION WITH THE CYTOLYTIC MONOCLONAL-ANTIBODY CAMPATH-1
    WIESNETH, M
    BUNJES, D
    SCHMEISER, T
    FRICKHOFEN, N
    ARNOLD, R
    HEIT, W
    BLUT, 1984, 49 (03): : 293 - 293
  • [37] T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
    JACOBS, P
    WOOD, L
    WALDMANN, H
    HALE, G
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 679 - 679
  • [38] PREVENTION OF ACUTE GVHD IN ALLOGENEIC BONE-MARROW TRANSPLANTATION BY INVITRO TREATMENT WITH THE MONOCLONAL ANTI-LYMPHOCYTE ANTIBODY CAMPATH-1
    WIESNETH, M
    BUNJES, D
    ARNOLD, R
    SCHMEISER, T
    HALE, G
    HEIMPEL, H
    HEIT, W
    EXPERIMENTAL HEMATOLOGY, 1985, 13 : 146 - 146
  • [39] ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY INVITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)
    WALDMANN, H
    HALE, G
    CIVIDALLI, G
    WESHLER, Z
    MANOR, D
    RACHMILEWITZ, EA
    POLLIAK, A
    OR, R
    WEISS, L
    SAMUEL, S
    BRAUTBAR, C
    SLAVIN, S
    LANCET, 1984, 2 (8401) : 483 - 486
  • [40] GRAFT-VERSUS-HOST DISEASE PREVENTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM HISTOCOMPATIBLE SIBLINGS - A PILOT-STUDY USING IMMUNOTOXINS FOR T-CELL DEPLETION OF DONOR BONE-MARROW
    FILIPOVICH, AH
    VALLERA, DA
    YOULE, RJ
    HAAKE, R
    BLAZAR, BR
    ARTHUR, D
    NEVILLE, DM
    RAMSAY, NKC
    MCGLAVE, P
    KERSEY, JH
    TRANSPLANTATION, 1987, 44 (01) : 62 - 69